Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Hepatology. 2014 Sep 29;60(5):1571–1580. doi: 10.1002/hep.27310

Table 2.

Logistic regression analysis of factors associated with being in a phylogenetic pair/cluster for participants with HCV genotype 1a or 3a in the VIDUS cohort, 1996-2012, Vancouver, Canada.

Characteristic Overall Not cluster Pair/cluster Membership in pair/cluster (n ≥ 2)
Univariate Multivariate
Total n (%) (n=501) (n = 345) (n=156) Odds ratio 95% CI P Odds ratio 95% CI P
Female sex (vs. male sex) 121 (24%) 78 (23%) 43 (28%) 1.30 0.85 - 2.01 0.231 - - -
Age <40 years (vs. ≥40 years) 340 (68%) 221 (64%) 119 (76%) 1.80 1.17 - 2.77 0.007 1.63 1.05 - 2.53 0.028
High school education or higher (vs. less than high school)* 91 (18%) 59 (17%) 32 (21%) 1.26 0.78 - 2.03 0.350 - - -
Unstable housing (vs. stable) 352 (70%) 246 (71%) 106 (68%) 0.85 0.57 - 1.28 0.447 - - -
HCV Genotype 3a 190 (38%) 125 (36%) 65 (42%) 1.26 0.85 - 1.85 0.246 - - -
Recent HCV seroconversion (vs. not) 31 (6%) 16 (5%) 15 (10%) 2.34 1.11 - 4.92 0.025 3.05 1.4 - 6.66 0.005
HIV infection (vs. none) 131 (26%) 79 (23%) 52 (33%) 1.68 1.11 - 2.55 0.014 1.82 1.18 - 2.81 0.006
Currently enrolled in methadone treatment (vs. yes) 64 (13%) 47 (14%) 17 (11%) 0.77 0.43 - 1.39 0.386 - - -
Syringe borrowing (vs. none) 205 (41%) 130 (38%) 75 (48%) 1.53 1.04 - 2.24 0.029 1.59 1.07 - 2.36 0.022
Crack use (vs. none) 123 (25%) 88 (26%) 35 (22%) 0.84 0.54 - 1.32 0.460 - - -
Cocaine injecting (vs. none) 424 (85%) 286 (83%) 138 (88%) 1.58 0.9 - 2.78 0.112 - - -
Heroin injecting (vs. none) 370 (74%) 255 (74%) 115 (74%) 0.99 0.64 - 1.52 0.963 - - -
Speedball injecting (vs. none) 213 (43%) 140 (41%) 73 (47%) 1.29 0.88 - 1.88 0.193 - - -

Percentages indicate column percentages

*

At the time of enrolment

in the last 6 months prior to enrolment.

Abbreviations: HIV = human immunodeficiency virus; HCV hepatitis C virus.